Related references
Note: Only part of the references are listed.PRAME-Specific Allo-HLA-Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer
Avital L. Amir et al.
CLINICAL CANCER RESEARCH (2011)
Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies
Marleen M. van Loenen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Simultaneous Isolation of CD8+ and CD4+ T Cells Specific for Multiple Viruses for Broad Antiviral Immune Reconstitution After Allogeneic Stem Cell Transplantation
Maarten L. Zandvliet et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Kinetic Preservation of Dual Specificity of Coprogrammed Minor Histocompatibility Antigen-Reactive Virus-Specific T Cells
Marleen M. van Loenen et al.
CANCER RESEARCH (2009)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CD8α/α homodimers fail to function as co-receptor for a CD8-dependent TCR
Anne-Marie McNicol et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Facilitating matched pairing and expression of TCR chains introduced into human T cells
Jurgen Kuball et al.
BLOOD (2007)
Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex
Mirjam H. M. Heemskerk et al.
BLOOD (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Generation of T cell help through a MHC class I-Restricted TCR
Helmut W. H. G. Kessels et al.
JOURNAL OF IMMUNOLOGY (2006)
Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells
KBJ Scholten et al.
CLINICAL IMMUNOLOGY (2006)
Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer
MHM Heemskerk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector
AL Szymczak et al.
NATURE BIOTECHNOLOGY (2004)
Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region
MHM Heemskerk et al.
BLOOD (2003)
Stable, soluble T-cell receptor molecules for crystallization and therapeutics
JM Boulter et al.
PROTEIN ENGINEERING (2003)
CD8β endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56lck complexes
A Arcaro et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Immunotherapy through TCR gene transfer
HWHG Kessels et al.
NATURE IMMUNOLOGY (2001)
Peptide-MHC class I tetrameric complexes display exquisite ligand specificity
SR Burrows et al.
JOURNAL OF IMMUNOLOGY (2000)
Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes
LJN Cooper et al.
JOURNAL OF VIROLOGY (2000)